Presence of human papillomavirus infection determined by hybrid capture assay in cervical lesions in a Venezuelan population

Investigacion Clinica

Volumn 51, Issue 1, 2010, Pages 27-35

  Correnti, Maria ^a   Cavazza, María Eugenia ^b   Herrera, Odalis ^c   Rodríguez, Armando ^c  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b INSTITUTO DE BIOMEDICINA   (Venezuela)

^c Laboratorio Citomed   (Venezuela)

Author keywords

Cervical cancer; HCA II; HSIL; Human papillomavirus; LSIL; Venezuela

Indexed keywords

VIRUS DNA; DNA PROBE;

ADULT; ARTICLE; CANCER RISK; CYTODIAGNOSIS; FEMALE; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PREVALENCE; UTERINE CERVIX DISEASE; VENEZUELA; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS; DNA PROBE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVIX TUMOR; VIROLOGY; YOUNG ADULT;

ADULT; DNA PROBES, HPV; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; UTERINE CERVICAL NEOPLASMS; VENEZUELA; YOUNG ADULT;

EID: 77953263613     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Skerlev M, Giri M, Skerlev HS. Human Papillomavirus male genital infections: Clinical variations and the significance of DNA typing. Clinics Dermatol 2002; 20:173-178. (Pubitemid 34406434)
2. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incident and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36: 6-10.
3. Van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, Denkers F, Smeele LE, Snow GB, Brakenhoff RH. Biological evidence that human papillomavirus are etiologically envolved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 2001; 93:232-235. (Pubitemid 32574279)
4. Koutsky LA, Kiviat NB. Genital human papillomavirus. In: Holmes K, Sparling, P. Mardh P, Lemon S, Stamm W, Piot P, Wasserheit J. Sexually Transmitted Diseases, 3rd edition. New York: McGraw-Hill, 1999, p. 347-359.
5. World Health Organization. IARC monograph on the evaluation of carcinogenic risk to humans: human papillomavirus. 1995. Lyons, France, IARC; 2000.
6. Hong D, Ye F, Chen H, Lu W, Cheng O, Hu Y, Xie X. Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China. Int J Gynecol Cancer 2008; 18(1):104-109.
7. NIH Consensus Statement Cervical Cancer. NIH Consensus Statement 1996; 1-38.
8. Muñoz N, Bosch FX, de Sanjose S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:518-527. (Pubitemid 36159887)
9. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87:796-802.
10. Bosch FX, de Sanjosé S. The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 2007; 23:213-227. (Pubitemid 47015785)
11. Walboomers JM, Jacobs MV, Manos MM, Bosch X, Kunmmer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-19. (Pubitemid 29406813)
12. Pereira CR, Rosa ML, Vasconcelos GA, Faria PC, Cavalcanti SM, Oliveira LH. Human papillomavirus prevalence and predictors for cervical cancer among high-risk women from Rio de Janeiro, Brazil. Int J Gynecol Cancer 2007; 17(3):651-660.
13. Kreimer AR, Clifford GM, Boyle P, Franceski S. Human Papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14:467-475.
14. Liuzzi J, Estanga N, Castillo L, Correnti M, Mijares A, Gardie J. Tipificación del virus del papiloma humano en carcinoma de células escamosas de cabeza y cuello. Rev Venez Oncol 2007; 19:210-218.
15. Correnti M, Rivera H, Cavazza ME. Detection of human Papillomavirus of high oncogenic potential in oral squamous cell carcinoma in a Venezuelan population. Oral Dis 2004; 10:163-166.
16. Jimenez C, Correnti M, Salma N, Cavazza ME, Perrone M. Detection of human papillomavirus DNA in benign oral squamous epithelial lesions in Venezuela. J Oral Pathol Med 2001; 30:385-388.
17. Marais D, Constant D, Allan B, Carrara H, Hoffman M, Shapiro S, Morroni C, Williamson A. Cervical Human Papillomavirus (HPV) Infection and HPV Type 16 Antibodies in South African Women. J Clin Microbiol 2008; 732-739.
18. Markowitz LE, Dunne EF, Saraiya M, Lawson H, Unger ER. Centres for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Pep 2007; 56:1-24.
19. Carestiato F, Silva K, Dimetz T, Oliveira L, Cavalcanti S. Prevalence of human papillomavirus infection in the genital tract determined by hybrid capture assay. Bras J Infect Dis 2006; 10(5):331-336.
20. Carozzi F, Bisanzi S, Sani C, Zappa M, Cechini S, Ciatto S, Confortini M. Agreement between the AMPLICOR human papillomavirus test and the hybrid capture 2 assay in detection of High-Risk Human Papillomavirus and Diagnosis of Biopsy-Confirmed High Grade Cervical Disease. J Clin Microbiol 2007; 45: 364-369.
21. Knoepp SM, Kuebler DL, Wilbur DC. Resolution of equivocal resultas with Hybrid Capture II high-risk HPV DNA test: a cytologic/ histologic review of 191 cases. Diag Mol Pathol 2007; 16:125-129.
22. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologist diagnosis of ASCUS. Am J Obstet Gynecol 1995; 172: 946-954.
23. Wright TC Jr, Stewart-Massad L, Dunton Ch J, Spitzer M, Wilkinson EJ, Solomon D. Consensus guidelines for the management of women with abnormal cervical cancer screening tests. AJOF 2006; 197(4):346-355.
24. Parkin DM, Bray FI, Devessa SS. Cancer Burden in the year 2000. The global Picture. Eur J Cancer 2001; 37 (Suppl 8): s4-s66.
25. Camara GL, Cerqueira D, Oliveira A, Silva E, Carvalho L, Martins C. Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil. Mem Inst Oswaldo Cruz 2003; 98:879-883. (Pubitemid 38019535)
26. Giuliano A, Papenfuss M, Abrahamsen M, Denman C, de Zapien J, Navarro JL, Ortega L, Brown E, Stephan J, Feng J, Baldwin S, Garcia F, Hatch K. Human Papillomavirus Infection at the United Status-Mexico Border: Implications for Cervical Cancer Prevention and Control. Cancer Epidemiol Biomarkers Prev 2001; 1129-1136. (Pubitemid 33064300)
27. Arrosi S, Sankaranayanan R, Maxwell D. Incidente and mortality of cervical cancer in Latin America. Salud Pública Mex 2003; 45:S306-S314.
28. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995; 76:1888-1901.
29. Carvalho MO, Carestiato FN, Perdigao PH, Xavier MPPT, Silva KC, Botelho MO, Oliveira LHS, Cavalcanti SMB. Human Papillomavirus infection in Rio de Janeiro, Brazil: a Retrospective Study. Braz J Infect Dis 2005; 9: 398-404. (Pubitemid 43130807)
30. Tonon SA, Picconi MA, Zinovich JB, Nardari W, Mampaey M, Galuppo JA, Bos PD, Badano I, Di Lello F, Basiletti J, González JV, Alonio LV, Teyssie AR. Prevalence of cervical infection by human papillomavirus 8HPV) in the Caucasian and Guarani populations residing in the Provence of Misiones, Argentina. Rev Argent Microbiol 2003; 35:205-213. (Pubitemid 38084005)
31. Molano M, Posso H, Weiderpass E, van der Brule AJ, Ronderos M, Franceschi S, Meijer CJ, Arslan A, Munoz N. HPV Study Group HPV Study. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Int J Cancer 2001; 91:412-420.
32. Lazcano E, Herrero R, Muñoz N, Cruz A, Shah K, Alonso P, Hernandez, Salmerón J, Hernandez M. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001; 91:412-420. (Pubitemid 32049638)
33. Herrero R, Hildesheim A, Bratty C, Sherman M, Hutchinson M, Morales J, Balmaceda L, Greenberg L, Alfaro M, Burk R, Wacholder S, Plummer M, Schiffman M. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst (Bethesda) 2000; 92: 464-474. (Pubitemid 30182883)
34. Bosch XJ, Munoz N, de Sanjose S, Izarzugaza L, Pili M, Viladiu P, Tormo M, Moreo P, Aschunce N, Gonzalez LC, Tafur L, Kaldor JM, Guerrero E, Aristizabal N, Santamaria M, Alonso-Ruiz P, Shah K. Risk factors for cervical cancer in Colombia and Spain. Int Cancer 1992; 32:750-758.
35. Mendoza JA, Muñoz M, Vielma S, Noguera ME, López M, Toro M. Infección cervical por el virus del papiloma humano: diagnóstico por citología y por captura de híbridos del ADN viral. Rev Obst Ginecol Venez 2000; 60:103-107.
36. Contreras-Irrazabal L, Correnti M, Ávila M, Guerrero A, León A. Virus Papiloma Humano (VPH) en contexto ecológico venezolano (I): Diagnóstico citológico y molecular. Salus 2008, 12, 3:30-44.
37. Muñoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith IS, Shah KV, Meijer CJ, Bosch FX. Role of parity and human papillomavirus in cervical cancer: The IARC multicentric case-control study. Lancet 2002; 359:1093-1101. (Pubitemid 34270732)
38. Moreno V, Bosch FX, Muñoz N, Meijer CJ, Shah KV, Walboomers IM, Herrero R, Franceschi S. Effect of oral contraceptives on risk of cervical cancer in women with human Papillomavirus infection: The IARC multicentric case-control study. Lancet 2002; 359:1085-1092. (Pubitemid 34270731)
39. Callaghan J, Karim S, Mortlock S, Winter M, Woodward N. Hybrid capture as a mean of detecting human papillomavirus DNA from liquid-based cytology specimens: a preliminary evaluation. Brit. J Biomed 2001; 58; 184-189. (Pubitemid 32906907)
40. Morrison H. Human Papillomavirus absence predicts normal cervical histopathologic findings with abnormal Papanicolau smears. J Hum Virol 1993; 4: 283-287.
41. Cavalcanti SMB, Zardo LG, Pasos MRL, Oliveira LHS. Epidemiological aspects of Human papillomavirus infection and cervical cancer in Brazil. J Infection 2000; 40:80-87. (Pubitemid 30157779)